Evidence map›Paper›PMID 38187993›Full record

ArticleQatar medical journal2023

Determinants of vaccine adherence among non-dialysis chronic kidney disease patients in Qatar.

Mhd Baraa Habib, Khaled Ali, Alaa Rahhal, Ibrahim Obeidat, Mohammed Altermanini, Bisher Sawaf, Tarek Abdel Latif, Abdullah Hamad, Iheb Bougmiza, Sahar Ismail Aly and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Qatar medical journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Mhd Baraa HabibInternal Medicine Department, Hamad Medical Corporation, Doha, Qatar.
Khaled AliCommunity Medicine Department, Hamad Medical Corporation, Doha, Qatar Email:kali15@hamad.qa ORCID iD: 0000-0002-8073-4375.
Alaa RahhalPharmacy Department, Hamad Medical Corporation, Doha, Qatar.
Ibrahim ObeidatInternal Medicine Department, Hamad Medical Corporation, Doha, Qatar.
Mohammed AltermaniniInternal Medicine Department, Hamad Medical Corporation, Doha, Qatar.
Bisher SawafInternal Medicine Department, Hamad Medical Corporation, Doha, Qatar.
Tarek Abdel LatifNephrology Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Abdullah HamadNephrology Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Iheb BougmizaCommunity Medicine Department, Primary Health Care Corporation, Doha, Qatar.
Sahar Ismail AlyNephrology Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Khaled Mohamed MahmoudNephrology Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Hamad Medical Corporation · QAPrimary Health Care · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionChronic kidney disease (CKD) is a global health problem. Reduced innate and adaptive immunological responses predispose CKD patients to infections. Despite the clinical and epidemiological importance of CKD and the great value of vaccination as a prophylactic measure, the utilization of recommended vaccines in Qatar has not yet been evaluated.

methodsWe conducted a cross-sectional study to estimate the level of influenza, pneumococcal, and hepatitis B vaccination and the predictors of adherence to these recommended vaccines among non-dialysis CKD patients receiving renal ambulatory care in Qatar from 1 September 2020 to 30 April 2021. Complete vaccination was defined as receiving the three vaccines, and partial vaccination was defined as receiving one or two vaccines. The full and partial vaccination predictors were assessed using multivariate logistic regression and reported as odds ratio (OR) with p<0.05 indicating statistical significance.

results416 non-dialysis CKD patients were included in our analysis. 73% were males; the mean age was 56 ± 15 years. More than 50% of the patients were from the Middle East, followed by 36% from Asia. Most patients had concurrent hypertension, concurrent diabetes mellitus, and were stage V CKD. Only 12% of the patients were fully vaccinated, while 73% received partial vaccination. The predictors of vaccination included age, gender, Asian origin, employment, living conditions, concurrent medical conditions, CKD stage, allergy to medications, and use of injectable medications. Only stage V CKD positively predicted adherence to full and partial vaccinations in non-dialysis CKD patients.

conclusionThere is very low adherence to the recommended vaccines in CKD patients, with a prevalence of complete vaccination of 12% only. Increased public awareness about the importance of vaccination in CKD may improve the adherence rates among these patients in Qatar.

Indexed as

adherencechronic kidney diseasehepatitis Binfluenzapneumococcalvaccine

Identifiers

PMID38187993
PMCPMC10770734
OpenAlexW4390539593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.